Almirall’s New Psoriasis Campaign Sheds Light on How the Disease Affects Mental Health and Wellbeing

October 28, 2022
Almiralls New Psoriasis Campaign Sheds Light on How the Disease Affects Mental Health and Wellbeing image

World Psoriasis Day 2022 takes place on October 29th.

Almirall and the International Federation of Psoriasis Association are launching the second edition of the "Shedding Light on Psoriasis" campaign for World Psoriasis Day 2022.

Shedding Light on Psoriasis aims to elevate the stories of people living with psoriasis and show how the dark side of psoriasis affects their mental health, quality of life and the stigma they suffer from society. To do this, renowned illustrator Beatriz Ramo (@naranjalidad) has created a portrait of two people with psoriasis painting their journey with psoriasis: the struggles and achievements they have made throughout their lives.

"It doesn't make sense to just treat my pain, treat my flare-ups, I also need to support my mental health because we know that stress and other things are a trigger for those outbreaks. We also must relate the family to that, because lack of confidence related to flare-ups can affect our relationships, careers and finances. A multidisciplinary approach to psoriasis needs to be emphasised,” says Joel Nelson, IFPA ambassador and one of the main protagonists of the campaign, in a news release.

“The goal for World Psoriasis Day 2022 is to raise awareness between psoriatic disease and mental health. We need to support the unloading of the burden for people living with psoriatic disease and increase the wellbeing of those affected. Thank you, Almirall, for supporting IFPA in this journey and for giving the space for people living with the disease to speak up and share their stories”, adds Frida Dunger, IFPA's Executive Director.

“The link between psoriasis and the impact on mental health is well documented. At Almirall, we are committed to continuing raising awareness of the daily challenges faced by psoriasis patients and through campaigns such as Shedding Light on Psoriasis, we are successfully highlighting the importance of finding approaches that correctly capture the full impact of psoriasis on patients' lives,” says  Volker Koscielny, Almirall’s Chief Medical Officer. “It is important for us to stand by the patient community to fulfil our purpose of transforming patients' lives by helping them realize their hopes and dreams for a healthy life,.


From left to right: Paolo Cionini (Almirall’s Chief Commercial Officer of EU & International), Frida Dunger (IFPA's Executive Director), Karina Chávez (IFPA ambassador and protagonist of the campaign), Gianfranco Nazzi (Almirall’s CEO), Isabel Gomes (Almirall’s General Counsel) and Volker Koscielny (Almirall’s Chief Medical Officer)


Facebook Comments


We’re glad to see you’re enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free